Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Worel, N; Shaw, BE; Aljurf, M; Koh, M; Seber, A; Weisdorf, D; Schwartz, J; Galeano, S; Kodera, Y; Eldridge, PW; Hashmi, S; Atsuta, Y; Szer, J; Saber, W; Niederwieser, D; Greinix, HT; Worldwide Network for Blood & Marrow Transplantation.
Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation.
TRANSPL CELL THER. 2021; 27(3): 270.e1-270270.
Doi: 10.1016/j.jtct.2020.11.019
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Greinix Hildegard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- SARS-CoV-2 has spread rapidly worldwide, but the full impact of the COVID-19 pandemic on the field of hematopoietic cell transplantation (HCT) remains unknown. To understand this better, an 18-item online survey was disseminated by the Worldwide Network for Blood & Marrow Transplantation with questions exploring SARS-CoV-2 testing algorithms, mobilization, and cryopreservation strategies and COVID-19 infections in allogeneic related and autologous hematopoietic progenitor cell (HPC) donors. The aim of this survey was to assess the impact of the outbreak on policies relating to HPC mobilization, collection, and processing with respect to changes in daily routine. A total of 91 individual responses from distinct centers in 6 continents were available for analysis. In these centers, the majority (72%) of allogeneic related and autologous donors are routinely tested for SARS-CoV-2 before HPC collection, and 80% of centers implement cryopreservation of allogeneic HPC grafts before commencing conditioning regimens in patients. Five related and 14 autologous donors who tested positive for COVID-19 did not experience any unexpected adverse events or reactions during growth factor administration (eg, hyperinflammatory syndrome). These data are limited by the small number of survey respondents but nonetheless suggest that centers are following the recommendations of appropriate scientific organizations and provide some preliminary data to suggest areas of further study. Copyright © 2020 The American Society for Transplantation and Cellular Therapy. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
- Algorithms -
- Allografts -
- Bone Marrow Transplantation - statistics & numerical data
- Bone Marrow Transplantation - trends
- COVID-19 - diagnosis
- COVID-19 - epidemiology
- COVID-19 - prevention & control
- COVID-19 Testing - methods
- COVID-19 Testing - statistics & numerical data
- Cryopreservation - methods
- Donor Selection - standards
- Global Health -
- Health Care Surveys -
- Hematopoietic Stem Cell Mobilization - statistics & numerical data
- Hematopoietic Stem Cell Transplantation - statistics & numerical data
- Hematopoietic Stem Cell Transplantation - trends
- Pandemics -
- Practice Patterns, Physicians' - statistics & numerical data
- Procedures and Techniques Utilization - statistics & numerical data
- SARS-CoV-2 -
- Tissue Preservation - methods
- Transplantation, Autologous -
- Unrelated Donors - statistics & numerical data
- Find related publications in this database (Keywords)
- COVID-19
- G-CSF
- Cryopreservation
- Mobilization